Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)
Sponsor: University Medical Center Goettingen
Summary
CMT is a rare disease for which novel treatments are being developed. Evaluation of intervention efficacy is hampered by slow progression and lack of sensitive outcome measures. Primary goal of the project is to identify and validate RNA and protein derived biomarkers in blood of CMT patients for selected outcome measures over 2 years. The investigators expect to develop more responsive outcome measures and circulating biomarkers to improve assessment of intervention efficacy in forthcoming therapeutic trials.
Key Details
Gender
All
Age Range
3 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
156
Start Date
2017-08-11
Completion Date
2019-09-30
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Locations (1)
University Medical Center Goettingen
Goettigen, Lower Saxony, Germany